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Abbreviated Words 
 
AdGFP: adenovirus vector including GFP 
AdMunc18b: Adenovirus vector including GFP gene and Munc18b 
cAMP: cyclic adenosine monophosphate 
CFP: cyan fluorescent protein 
Diabetes: diabetes mellitus 
GFP: green fluorescent protein  
GLP-1: glucagon-like peptide-1 
GLUT: glucose transporter 
GSIS: glucose-stimulated insulin secretion 
IBMX: isobutylmethylxanthine 
IP: immunoprecipitation 
lenti: lentivirus vector 
PM: plasma membrane 
SG: secretory granules 
SG-SG fusion: secretory granule fuse with a secretory granule fusion 
shRNA: short hairpin ribonucleic acid 
siRNA: small interfering ribonucleic acid 
SM (protein): Sec1/Munc18 protein 
SNAP25: synaptosomal-associated protein of 25 kDa 
SNARE (protein): soluble N- ethylmaleimide-sensitive factor attachment protein 
receptor protein 
Syn: Syntaxin 
VAMP: vesicle-associated membrane proteins 
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ABSTRACT 
Sec1/Munc18 proteins facilitate the formation of trans-SNARE (soluble N- 
ethylmaleimide-sensitive factor attachment protein receptor) complexes that mediate the 
fusion of secretory granules (SG) with the plasma membrane (PM). The ability of 
pancreatic β-cells to exocytose insulin is compromised in diabetes. β-cells express three 
Munc18 isoforms, Munc18a, b, and c. Munc18b was found in cells of many tissues that 
mainly indicated secretion model is sequential exocytosis, such as platelet cell and 
pancreatic acinar cell. The role of Munc18b was unknown. We found that Munc18b 
depletion in rat islets disrupted SNARE complex formation by Syntaxin (Syn)-2 and 
Syn-3. Two-photon imaging analysis showed that gain-of-function expression of 
wild-type Munc18b or the dominant-positive K314L/R315L mutant promoted the 
assembly of cognate SNARE complexes, which potentiated biphasic GSIS. The latter 
was attributed to a more than three-fold enhancement of both primary exocytosis and 
sequential SG-SG fusion, including long-chain fusion (6–8 SGs), which is not normally 
observed (normally 2–3 SG fusion). In contrast, two-photon imaging analysis showed 
that Munc18b depletion in β-cells reduced primary exocytosis (SG-PM fusion) by 40% 
and abrogated almost all sequential exocytosis (SG-SG fusion events), accounting for a 
41% reduction in glucose-stimulated insulin secretion (GSIS). Thus, Munc18b-mediated 
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exocytosis might be used to increase the secretory efficiency of SGs in deeper cytosolic 
layers of β-cells and increase primary exocytosis. Munc18b may open new avenues for 
the development of therapy for some of diabetes patients characterized by a dysfunction 
of insulin secretion.  
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INTRODUCTION  
Glucose stimulation of islet β-cells triggers an initial robust first phase of 
glucose-stimulated insulin secretion (GSIS), followed by a diminished but sustained 
second phase of GSIS. In type 2 diabetes, the islet insulin secretory capacity cannot 
meet the increasing insulin demand caused by insulin resistance. β-cells eventually 
decompensate with loss of first-phase GSIS, and second-phase GSIS becomes defective 
(1).  
Although previous studies have identified the molecular circuitry underlying 
β-cell stimulus-secretion coupling (reviewed in 2,3), the precise molecular determinants 
of the complex steps of insulin SG exocytosis at the plasma membrane (PM), termed 
primary exocytosis, remain unclear. In mast cells, eosinophils (4,5), and pancreatic 
acinar cells (6), rapid and extensive sequential SG-SG fusion accounts for the cells’ high 
secretory efficiency. Sequential SG-SG fusion also occurs in β-cells, but at a reduced 
frequency (1.9%–4.5%) and to a reduced extent (only 2–3 SGs) (7,8). Much less is 
known about the molecular machinery driving SG-SG fusion in β-cells.  
The membrane fusion machinery requires two key components: SNARE 
(soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins and 
Sec1/Munc18 (SM) proteins (9). The SNARE paradigm dictates that cognate vesicle 
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(v)-SNAREs (vesicle-associated membrane proteins [VAMPs]) and target membrane 
(t)-SNAREs (syntaxins [Syn] and synaptosomal-associated protein of 25 kDa 
[SNAP-25]) assemble into complexes that mediate different fusion events. The 
assembly of distinct SNARE complexes is regulated by cognate SM proteins to ensure 
subcellular compartmental specificity and that fusion only occurs in response to cellular 
needs and demands (3,10). Of three SM proteins, Munc18a is the best studied (10–12). 
Its roles include orchestrating SG docking and priming (13,14), chaperoning and 
inducing the activated conformation of Syn-1A (15–17), and facilitating membrane 
fusion (18,19). In β-cells, much is known about the roles of Munc18a and Syn-1A in 
mediating insulin exocytosis (20,21). Munc18c and the cognate molecule Syn-4 mediate 
GLUT-4 translocation to the PM in adipose tissue and muscle and also mediate some 
aspects of GSIS (3). Relatively little is known about Munc18b, which preferentially 
binds Syn-2 and Syn-3 (22). 
Here, my collaborators, Dr. Gaisano and his colleagues, examined the 
expression and localization of the Munc18 proteins in pancreatic β-cells and INS-1 cells 
using western blot and confocal microscopy with fluorescent antibodies. Rat islets and 
INS-1 cells expressed all three SM proteins (Munc18a, Munc18b, Munc18c), the four 
cognate syntaxins (Syn-1A, -2, -3, -4), SNAP-25, VAMP-2, and VAMP-8 (Appendix 
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Fig. 1). Syn-1A and Munc18a, which drive primary exocytosis (21), were abundant in 
the PM. Munc18c is thought to localize to the PM (23). On the other hand, Munc18b, 
Syn-2, and Syn-3 localized on insulin SGs, though not exclusively (Appendix Fig. 2). 
With regard to insulin secretion, they examined the effects of deleting 
Munc18b and overexpressing Munc18b wild-type and mutant proteins, which either 
facilitated (Munc18b-K314L/R315L [Munc18b-KR]) or suppressed (Munc18b-E59K) 
SNARE assembly in INS-1 cells, rat insulin-secreting cell line. In radioimmunoassays 
(RIA), depletion of Munc18b (86%, on average) with two siRNAs (siMunc18b nos. 1 
and 2) in INS-1 cells decreased 10 mM GSIS by ~40% (data not shown). Next they 
used lenti-shRNAs (co-expressing eCFP) to reduce Munc18b expression in rat islets (24 
h, 32%; 48 h, 75%; and 72 h, 97%; all P < 0.05; Appendix Fig. 3A). GSIS with 16.7 
mM glucose was assessed using the islet perifusion assay. Munc18b depletion resulted 
in a 44% reduction in GSIS (area under the curve [AUC] analysis: Munc18b shRNA, 
25.79 ± 2.49 vs. control, 45.54 ± 2.37; P < 0.001). The addition of cAMP-acting GLP-1 
(10 nM with 150 μM IBMX) potentiated GSIS approximately three-fold (Appendix Fig. 
3B). Munc18b depletion reduced the GLP-induced potentiation by ~52% (Munc18b 
shRNA, 68.63 ± 19.3 vs. control, 132.14 ± 17.15; P < 0.05). IBMX, a 
phosphodiesterase inhibitor that increases intracellular cAMP levels, was added with 
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GLP-1 to improve consistency. The results from shRNA in rat islets accorded with 
siRNA results in INS-1 cells.  
My collaborators, Dr. Kauppi and her colleagues, previously reported that 
Munc18b-WT preferentially binds Syn-2 and Syn-3 and that Munc18b mutants 
generated by them exhibit weaker binding (Munc18b-KR) or no binding 
(Munc18b-E59K) to the syntaxins (22), mentioned the details of these mutatnts later in 
this section. They subcloned these proteins, along with enhanced GFP to identify 
transfected cells (for two-photon studies), into adenoviral vectors to transduce islets and 
INS-1 cells. AdMunc18b-WT or mutants expression were ~4–5 times higher than that of 
endogenous Munc18b expression (Appendix Fig. 4A). The recombinant proteins were 
expressed in 60%–70% of islet cells (based on visualization of GFP with confocal 
microscopy). Syn-2 and Syn-3 localization to insulin SGs was not affected by 
overexpression of any of the three Munc18b proteins (Appendix Fig. 4) (analysis with 
Pearson correlation (24); data not shown here). Moreover the protein and mRNA 
expression of endogenous SNAREs and Munc18s was unaffected in transfected islets. 
Then they examined the effects of the AdMunc18 and AdMunc18b mutants on biphasic 
16.7 mM GSIS (Appendix Fig. 5A) and 16.7 mM GSIS with GLP-1 and IBMX 
(Appendix Fig. 5B). The AUC of insulin secretion on potentiated GSIS was 
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approximately four- to ﬁve-fold higher than that on 16.7mM GSIS without accelerants. 
AdMunc18b-WT potentiated ﬁrst-phase GSIS (12–22 min) by 63% (20.1 ± 2.2 vs. 
AdGFP 12.3 ± 1.6; P = 0.03) and second-phase GSIS (22–40 min) by 43% (36.0 ± 1.6 
vs. AdGFP 25.2 ± 1.8; P = 0.02). AdMunc18b-KR potentiated ﬁrst-phase GSIS by 95% 
(24.0 ± 3.1; P = 0.003) and second-phase by 83% (46.2 ± 4.2; P = 0.003). The effect of 
AdMunc18b-KR was stronger than that of AdMunc18b-WT. AdMunc18b-E59K was 
expected to inhibit GSIS, but did not cause a signiﬁcant reduction (10.1 ± 2.4 and 21.5 ± 
3.6 for ﬁrst and second phases, respectively). The effects on first-phase and 
second-phase potentiated GSIS (Appendix Fig. 5B) were remarkably similar to those 
observed with 16.7 mM GSIS. GSIS in cells expressing AdMunc18b-KR (87.0 ± 1.4 
and 257.4 ± 5.5) was higher than in those expressing AdMunc18b-WT (56.6 ± 3.4 and 
198.1 ± 20.9), which in turn was higher than in cells expressing AdGFP (46.4 ± 3.4 and 
136.1 ± 4.3). Potentiated GSIS in cells expressing AdMunc18b-E59K (40.7 ± 3.9 and 
162 ± 12.3) and GFP was not signiﬁcantly different. The effects of the Munc18b 
proteins on GSIS in INS-1 cells (Appendix Fig. 5B) were similar to those in islets. 
Basal insulin release was not affected by the AdMunc18b mutants. AdMunc18b-KR 
expression potentiated GSIS (10 mM; determined as stimulated minus basal values) by 
98% (2.14% ± 0.09% vs. AdGFP 1.08% ± 0.80%; P < 0.05). AdMunc18b-WT 
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expression potentiated GSIS by 48% (1.60% ± 0.11%; P < 0.05), thus to a lesser extent 
than AdMunc18b-KR (P = 0.007). AdMunc18b-E59K had no signiﬁcant effect (0.86% ± 
0.05%). Potentiated GSIS (10 nM GLP-1 plus 150 μM IBMX) (Appendix Fig. 4B) was 
approximately four times higher than 10 mM GSIS and had a trend similar, wherein 
AdMunc18b-KR (7.71% ± 0.59%) and AdMunc18b-WT (5.99% ± 0.19%) increased 
secretion by 68% and 30%, respectively, over that induced by AdGFP (4.60% ± 0.16%; 
P < 0.05), with AdMunc18b-KR inducing higher secretion than AdMunc18b-WT (P = 
0.012). AdMunc18b-E59K (4.98% ± 0.22%) did not have a signiﬁcant effect when 
compared with AdGFP. Thus, the effects of Munc18b knockdown and the Munc18b 
mutants on GSIS were similar in INS-1 and β-cells. 
Then they examined protein pull down assay to elucidate the relation between 
Munc18b and Syn, and the formation of distinct SM-activated SNARE complexes. The 
INS-1 cell line was used as a surrogate for β-cells to provide the amount of protein 
required for protein binding studies. The coimmunoprecipitation experiments were 
performed with antibodies to Syn-1A, Syn-2, and Syn-3 using lysates from INS-1 cells 
transfected with scrambled siRNA (control) or Munc18b-siRNA and cultured under 
non-stimulatory (0.8 mmol/L glucose) or maximal stimulatory conditions (preincubation 
with GLP-1 and IBMX followed by incubation with 16.7 mM glucose) (Appendix Fig. 
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6, left panels, coimmunoprecipitation; right panels, total lysate input controls). In 
control scrambled siRNA-treated cells under non-stimulatory conditions, Syn-2 
(Appendix Fig. 6B) and Syn-3 (Appendix Fig. 6C) bound Munc18b, but little binding to 
VAMPs or SNAP25 was observed. Only upon stimulation, which presumably activates 
Munc18b, did we observe formation of full and distinct SNARE complexes, with Syn-3 
preferentially binding VAMP8 and Syn-2 binding both VAMPs (VAMP2 > VAMP8). 
These results are consistent with our previous findings that VAMP8 forms complexes 
with Syn-2 and Syn-3 (but not Syn-1), which mediates the primary exocytosis of 
newcomer insulin SGs (25) and SG-SG fusion. The latter was also observed in 
pancreatic acinar cells (26). Remarkably, Munc18b depletion with siRNA nearly 
prevented Syn-2 (Appendix Fig. 6B) and Syn-3 (Appendix Fig. 6C) from forming 
complexes with VAMPs and SNAP25. The disruption of SNARE complexes 
coimmunoprecipitated with the Syn-3 antibody matched the ~80% reduction in 
Munc18b levels analysed by quantitative densitometry from Appendix fig. 6; the 
disruption of SNARE complexes coimmunoprecipitated with the Syn-2 antibody was 
slightly lower (~70%) (Appendix Fig. 6B). This is remarkable considering the total 
cellular levels of the SNARE proteins in the cells, as shown in the inputs. The control 
cells were unaffected, and the proteins were expected to be available to participate in 
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SNARE complex formation. Munc18b depletion did not affect the amount of 
coimmunoprecipitated Munc18a, indicating that formation of SNARE complexes by 
Syn-2 and Syn-3 is primarily mediated by Munc18b. In contrast, Syn-1A 
coimmunoprecipitated endogenous Munc18a and formed complexes with SNAP25 and 
VAMP2 (Appendix Fig. 6A) in spite of Munc18b depletion, indicating that Munc18a 
but not Munc18b is the primary SM protein to activate Syn-1A to form SNARE 
complexes. Furthermore, the association of Munc18b with native β-cell syntaxin within 
assembled SNARE complexes was unaffected by Munc18b-WT or Munc18b-KR 
expression under basal and stimulatory conditions but was compromised by 
Munc18b-E59K expression (Appendix Fig. 7). These results differ from those of 
previous IP study (22), in which Munc18b-KR exhibited reduced association and 
Munc18b-E59K displayed almost no binding to uncomplexed recombinant syntaxin. 
This emphasizes the importance of analyzing mutants in native cells, where other 
exocytotic protein cooperate with SNARE and SM proteins on insulin exocytosis, 
because we also showed that the number of SM-activated SNARE complexes increased 
under stimulated conditions. From AdMunc18b-KR-expressing and AdMunc18b-WT 
-expressing cells, more SM-activated SNARE complexes were precipitated than from 
control cells. Munc18b-KR associated with Syn-1A, Syn-2, and Syn-3 SNARE 
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complexes to a greater extent than did Munc18b-WT. Syn-3, which putatively mediates 
SG-SG fusion (26), formed a complex with Munc18b to immunoprecipitate VAMP8 
exclusively, along with SNAP25 (Appendix Fig. 7C). A caveat of these 
coimmunoprecipitation studies is that syntaxin antibodies might pull down SM proteins 
independently from SNARE complexes. Because Munc18b also binds Syn-1A (27), 
Munc18b formed SNARE complexes with Syn-1A, SNAP25, and, preferentially, 
VAMP2 (Appendix Fig. 7A). These actions of Munc18b mutants on Syn-1A mimicked 
that of Munc18a. Thus, Munc18b likely has functions similar to those of Munc18a in 
mediating primary exocytosis. The induction of SM-SNARE complex formation by 
Munc18b proteins followed the order KR > WT > GFP > E59K (detailed data analyzed 
from Appendix Fig. 7 were not shown here, but in Supplementary Fig. 4 of our 
published article in Diabetes 2013 (24)), corresponding to the abilities of the proteins to 
potentiate biphasic GSIS (Appendix Fig. 5A). The role of Syn-2 in SNARE complex 
formation and in the broader ﬁeld of exocytosis is less clear. The fact that Munc18b 
proteins (KR > WT) induce Syn-2 to form SNARE complexes with VAMP2 and 
VAMP8 (Appendix Fig. 7B) and that such complexes are reduced by Munc18b 
depletion (Appendix Fig. 6B) suggests that Syn-2 might have functions redundant with 
those of Syn-1A and Syn-3. 
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Munc18b-E59K bound the syntaxins under basal conditions, but upon 
stimulation, it did not induce the syntaxins to bind SNAP25 or VAMPs. In addition, the 
levels of SM-activated SNARE complexes in cells expressing Munc18b-E59K were 
similar to or lower than those in cells expressing AdGFP. Munc18b-E59K/Syn 
complexes were essentially functionally inert; they did not markedly compete with 
endogenous Munc18b in any function essential for secretion. It was concerned that this 
explains why GSIS in both Munc18b-E59K-expressing cells and GFP-expressing 
control cells did not indicate a significant change of reduction (Appendix Fig. 5) and 
why E59K does not work as dominant-negative.  
The aforesaid results from perifusion assay and protein assay (24) lead to three 
points: the post-stimulus assembly of SNAREs in response to glucose stimulation, 
which is consistent with the formation of SNARE complexes (28,29) in insulin 
exocytosis, the potentiation of assembly by Munc18b, which is similar to the result of 
liposome fusion assay of Munc18a associated with SNARE proteins (19), and the role 
as a positive regulator of Munc18b, as mutated Munc18b that cannot interact with 
syn-11 cause Familial hemophagocytic lymphohistiocytosis type 5 (FHL5), showing 
impaired degranulation in NK (Natural killer) cells and CTL cells (cytotoxic T 
lymphocyte), and severely impaired platelet α (CD 62P)– and δ (CD 63)–granule 
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secretion in response to thrombin stimulation from FHL-5 patients (30,31).  
Munc18b is abundant in the cells that characterized in a sequential secretion 
with long duration of secretion time scale in many hours, which has Munc18b, Syn-2, 
Syn-3, SNAP23, VAMPs, such as epithelial cells (e.g. airway and pancreas acini) and 
platelet. I wonder why Munc18b exhibit in insulin-secreting cells, i.e. INS-1 cell line 
and rat islets, where exocytosis model is mainly primary exocytosis. I made an 
assumption that Munc18b worked on only sequential exocytosis on limited frequency 
when Munc18a worked on only primary exocytosis, and two isoforms shared the 
respectively different functions. Overexpression of Munc18b may be capable of treating 
diabetes patients caused by dysfunction of insulin secretion. These assumptions led the 
idea that the augmentation of insulin exocytosis shown perifusion assay in 
overexpressed Munc18b islets consisted of the augmentation of sequential exocytosis, 
and imaging of sequential exocytosis, it might be two-SG sequential exocytosis, was 
more available in two photon microscopy. Now I used two mutants of Munc18b which 
enhanced or declined the formation of SM-SNARE complex, Munc18b-KR or 
Munc18b-E59K, the same products as the above mentioned results.  
The residues of 314 and 315 in Munc18b are located in a solvent accessible 
loop at domain3a, forming a hydrogen bond to Glu-170 of Syn-3 (22). PKC-induced 
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phosphorylation of neighbor Ser-313 which is conserved in Munc18b, reduced binding 
to syntaxin1 (maybe closed syntaxin) for neurotransmitter release (32). It was reported 
that the 226-314 residues in Munc18a interact with Mint-1 (Munc18-interacting 
protein1, recruit Munc18a to the region with neurexin rich for exocytosis, however  
Mint-1 and Mint-2 bind to Munc18a but not to Munc18b (33,34,35). Munc18b 
K314L/R315L double mutant (Munc18b-KR), changed lysine and arginine to leucine 
brought about changing of the characterize in solvent loop to hydrophobic by Olkkonen 
et al., was demonstrated that it caused a markedly reduction of binary with Syn-3, an 
increment of SNAP23 binding to Syn-3, and a possibility of augmentation in secretion, 
in vitro IP and in vivo caco-2 cell, which is human epithelial colorectal adenocarcinoma 
cell line (22). Binding protein assay with each isoform of closed Syntaxin showed that 
Munc18b-WT bind to Syn, (Syn-2 > Syn-3 > Syn-1A), Munc18b-KR bind less than half 
of WT (Syn-2 > Syn1 > Syn-3), in accordance with the IP result that showed weaker 
binding of Myc-Munc18b-KR to Syn-2 and no binding of Myc-Munc18b-E59K to 
Syn-2 and Syn-3 in CHO cells, Chinese Hamster Ovary cells, which has Syn-2 and 
Syn-3 endogenously (36).  
The residue E59 of Munc18a, whish interact with arginine-114 in Habc domain 
of Syn-1A by salt bridge (37,38). Munc18b-E59K was produced by changing glutamic 
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acid to lysine, which cannot interact with Syn because of changing the charge from 
negative to positive. Binding protein assay with each isoform of closed Syntaxin 
showed that Munc18b-E59K almost deplete (22). A recent result of Munc18a-EK 
showed the reduction of affinity to SNARE complex and severe defect in neuronal 
release, consistently similar mutant Munc18a-E59R by changing charge represented a 
reduction of the fusion rate in SNARE mediated liposome-fusion (18). The mutant of 
arginine-114 in Syn-1A for unavailable interaction to Munc18a (or Munc18b) was not 
affected the fusion rate, therefore it supposed that the interaction between Munc18a (or 
Munc18b) and SNARE complex is necessary for SNARE mediated fusion through E59 
of Munc18b, not via Habc domain of Syntaxin (13, 39). These residues are well 
conserved in both Munc18a and Munc18b. It is crucial that membrane fusion need an 
interaction between Munc18 and SNARE 4 herix bundle (19,40,41,42). Our results 
from Munc18-SNARE complex assembly after stimulation were consistent with above 
previous conclusions. Thus I used Munc18b-KR mutant as a mediator of the formation 
of activated SM-SNARE complexes, which intend to fusion strongly. Overexpressed 
Munc18b-E59K was used for suppressed function system. However it did not have an 
enough effect on insulin secretion due to endogenous Munc18b. Next I examined by 
shRNA to deplete endogenous Munc18b.  
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To examine how Munc18b modulates the dynamics of insulin vesicle 
exocytosis, I used two-photon microscopic imaging of exocytosis in β-cells of rat islets 
in which Munc18b had been overexpressed. A gain-of-function expression of 
Munc18b-WT or the Munc18b-KR mutant, which promotes SNARE complex assembly 
(22), greatly increased the two kinds of exocytotic events, as wells as the number of 
SGs involved in sequential SG-SG fusion. In contrast, I found that Munc18b 
contributed to 40% of primary exocytosis events and to all sequential SG-SG fusion 
events from depletion of endogenous Munc18b experiments. These results suggest that 
Munc18b plays an important role in both primary exocytosis and sequential exocytosis, 
and they are consistent with the idea that Munc18b facilitates insulin exocytosis through 
the post-stimulated formation of Munc18b/Syn-2 and Munc18b/Syn-3 SM/SNARE 
complexes. In addition, my results also indicate that Munc18b promotes the sequential 
SG-SG fusion of three or more insulin vesicles in warm environment by glucose 
stimulation with accelerants, especially including of “compound exocytosis”.  
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MATERIAL AND METHODS  
Rat islet isolation for two-photon microscopy  
Islets from Sprague Dawley rats (275–300 g) were isolated by collagenase digestion as 
described previously (43). The intact islets were infected with lentivirus carrying 
Munc18b-shRNA or AdMunc18b constructs. For two-photon microscopy assays, the 
preparations were cultured under a humidified atmosphere of 5% CO2 at 37°C in RPMI 
1640 medium supplemented with 10% FBS, 100 µU/ml penicillin, and 100 mg/ml 
streptomycin for 48 or 24 h before the assay. The cells were stimulated with glucose in 
the presence of 10 nM GLP-1 (Sigma-Aldrich, Shinagawa, Tokyo, Japan) and 150 μM 
IBMX (Sigma-Aldrich), as indicated. The experiments were approved by the Animal 
Care Committees of the University of Tokyo. 
 
Silencing Munc18b expression and adenovirus construction 
Endogenous Munc18b was silenced by lenti-shRNA in islets. For construction of 
lentiviruses, the pLKO-Munc18b-eCFP plasmid was created by modifying the 
previously described parental pLKO-Munc18b-puro plasmid (15). The 
puromycin-resistance gene was replaced with eCFP. The knockdown plasmid was 
co-transfected with psPAX2 and pMDG2 into HEK-293FT cells for the generation of 
recombinant lentiviruses, lenti-shRNA/Munc18b-eCFP and lenti-eCFP (control). 
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For overexpressed experiment, I used amplified adenoviruses including 
Munc18b-WT or Munc18b mutants tagged with GFP in a separate transcription cassette 
(22), given by Dr. Gaisano, my collaborator. 
 
Two-photon microscopy  
Exocytosis in rat islets was imaged with an inverted microscope (IX81; Olympus, 
Tokyo, Japan) and a laser-scanning microscope (FV1000; Olympus, Tokyo, Japan) 
equipped with a ×60 (NA = 1.2) water-immersion objective lens and a femtosecond 
laser (MaiTai; Spectra Physics, Mountain View, CA, USA), as previously described (28). 
GFP, CFP, and Alexa Fluor® 594 Hydrazide (Alexa 594, a polar fluorescent tracer; 
Molecular Probes, Life Technologies, Tokyo, Japan) were excited at 830 nm. The 
emitted fluorescence of GFP, CFP, and Alexa594 was collected through 525/25BP, 
490SP+570SP, and 605/35BP filters, respectively, because the emitted fluorescence of 
the fluorophores peaks at 509 nm, 477 nm, and 617 nm, respectively. 
 
Two-photon extracellular polar-tracer (TEP) imaging 
TEP imaging was performed to visualize the spatiotemporal patterns of exocytosis, as 
previously described (44,45). In short, glucose-stimulated insulin exocytosis was 
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imaged with a solution containing Alexa 594 (0.3 mmol/L) (7) in the presence of 10 nM 
GLP-1 and 150 μM IBMX. The temperature of the preparation was maintained at 
~32°C using a heating stage incubator (Tokai Hit Co, Ltd. Shizuoka, Japan). The 
frequencies of exocytosis were normalized to the value per 800 μm2 (≈ per cell). The 
structures of the islets were determined by placing Alexa 594 in the extracellular 
medium. The probe rapidly diffused into the intercellular spaces, but did not readily 
permeate the plasma membrane. Fluorescent puncta represented individual exocytosis 
events where the Alexa 594 tracer rapidly diffused into the internal cavity of a SG upon 
opening of the fusion pore, which has a diameter of 1.4 nm (8), thus allowing passage of 
Alexa 594, which has a minimum length of 1.4 nm (46). The vesicles were confirmed to 
be positive with anti-insulin antibody in a previous study (8).  
 
Detection of sequential exocytosis in TEP imaging 
Sequential exocytosis occurred far more frequently than predicted from coincidental full 
fusion of a vesicle followed by another vesicle. Such coincidental events, occurring 
within 1 min and within 0.5 μm laterally (b) and 1 μm axially (T = 2 μm) from the 
initial event, can be estimated from the frequency of exocytosis per membrane area (a) 
using Poisson statistics, as previously described (7). Given exocytosis frequencies of 7.7, 
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14.1, 26.4, and 5.4 eventscell-1min-1 in adenovirus (Ad)GFP-, AdMunc18b-WT-, 
AdMunc18b-KR-, and AdMunc18b-E59K-expressing islets, respectively, the 
proportions of random simultaneous events were estimated as 0.12–0.51, 0.22–0.92, 
0.42–1.73, and 0.086–0.36%, respectively, using the following equations (7):  
             … (1.1) 
Considering the slope of the plasma membrane relative to the focal plane,   is predicted 
to be between two data from (1.1) and (1.2). 
                      … (1.2) 
Then, the proportion of random simultaneous events was estimated as below. 
    
 
 
 
             … (1.3) 
 
Frequency distribution of SG diameters estimated by ΔV-TEP-IQ (image-based 
quantification) analysis of TEP imaging 
Using the ΔV-TEPIQ method, the fluorescence intensity of the vesicle (FV) was divided 
by FE, representing the fluorescence intensity per unit area in an xy-image of a solution 
with an infinite depth, as V = FV/FE/Pxy(0), where Pxy(0) is the efficiency of focal 
illumination (0.56 in my setup). The diameters of the SGs were calculated from the 
volumes of the SGs (47). 
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Statistical analysis 
All data were presented as the mean ± SEM. Student’s t-test was used to compare two 
variables, and ANOVA followed by Scheffé’s test or Tukey’s test was used for multiple 
parametric comparisons. The Mann-Whitney’s U test and Steel-Dwass test were applied 
for nonparametric comparisons. Significance was set at P < 0.05.  
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RESULTS  
Munc18b gain-of-function promotes sequential SG-SG fusion and primary 
exocytosis 
Although Munc18b may activate SNARE complex assembly, little is known about how 
these proteins function in GSIS in rat pancreatic islets or about their differential 
involvement in primary and secondary exocytosis. Sequential insulin SG-SG fusion has 
been visualized with two-photon imaging in β-cells (8). The technique is more suitable 
for the spatial and temporal imaging of sequential exocytosis and the analysis of its 
dynamics than other imaging tools such as electron microscopy (EM), confocal laser 
scanning microscopy (CLSM), and total internal reflection fluorescence microscopy 
(TIRFM) because it can capture the dynamics of insulin exocytosis in intact live islets. 
The process of sequential exocytosis might be mediated by the diffusion of SNAP25 
from the PM into sequentially fused SGs after the assembly of SNARE complexes (7). I 
postulated that Munc18b-activated SNARE complexes containing Syn-2 or -3 might 
increase sequential SG-SG fusion. To test this idea, I used two-photon imaging analysis 
to examine whether overexpression of Munc18b mutants affected primary exocytosis 
and SG-SG fusion. To maximally potentiate 20 mM glucose-stimulated insulin 
exocytosis, I used GLP-1 plus IBMX, which also potentiates sequential SG-SG 
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exocytosis (43). After confirming that no morphological abnormalities were present in 
adenoviral vector-transfected islets by extracellular polar-tracer Alexa, I examined GSIS 
with TEP imaging. 
First, I visualized single SG fusion and sequential SG-SG exocytosis described 
at “TEPimaging” in “Materials and Methods.” The imaging was taken by a fluorescence 
intensity of Alexa fluorescence from intercellular spaces and innercellular puncta which 
was now collapsing exocytic SG. Fig. 1 shows the full-fusion exocytosis of three single 
SGs (Fig. 1Ba, b, c from inset in Fig. 1Aa, b, c) in AdGFP-transduced rat islets. In Fig. 
1C, the vertical lines indicate the times when the images in Fig. 7B were acquired. The 
fusion of an insulin SG occurred at 1.2 s (white arrow in the second image of Fig. 7B 
indicates the direction of fusion), discharge of contents occurred at 2.4–4.9 s (dotted 
circle in Fig. 1B, right), and the SG collapsed into the PM for full fusion, which is 
schematically illustrated in Fig. 1D. Each islet transduced with Munc18b or a Munc18b 
mutant exhibited this type of single SG exocytosis, a universal style of insulin 
exocytosis in murine islets transfected with GFP or AdGFP. The most frequent mode of 
sequential exocytosis observed involved two SGs. An example is shown in Fig. 2B in an 
AdMunc18b-KR-transduced islet (Fig. 2B, inset in Fig. 2A). Here, the ﬁrst SG fused 
with the PM at 1.3 s (arrow 1 indicates the direction of fusion) and then partially 
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emptied (dashed circle at 4.4 s). A second SG, coming from another direction (arrow 2) 
and from deeper in the cytosol than the ﬁrst SG, fused <2 s later, at 5.6 s. The area of 
ﬂuorescence intensity was larger and brighter (temporal analysis in Fig. 2C) because it 
emanated from the fusion of two SGs, and the decline in fluorescence was slower than 
that shown in Fig. 1C, reﬂecting insulin cargo emptying and the eventual collapse of the 
compound granule into the PM (Fig. 2D). Two-granule sequential exocytosis was 
identified in islets expressing Munc18b or Munc18b mutants as well as in control cells 
expressing AdGFP. 
Using this analysis, I counted the total number of exocytotic events as 
determined by number of omega ﬁgures (exocytotic eventscell-1min-1 during 10 min 
[Fig. 3A]). Islets maintained the secretion of insulin after glucose stimulation with or 
without accelerants. Stable secretion over time was similar in each transfected group 
(Fig. 3A). Exocytosis within 2, 4, 5, and 7–10 minutes was higher in cells expressing 
WT Munc18b than in cells expressing AdGFP. Exocytosis in cells expressing 
Munc18b-KR was higher than in cells expressing AdGFP at all times and higher than in 
Munc18b-WT-expressing cells at most times. Exocytosis in Munc18b-E59K-expressing 
cells was lower than in Munc18b-WT or -KR transfected cells at all times, except for 9 
minutes in WT transfected cells, however exocytosis in E59K was similar to in AdGFP. 
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Primary events sustained exocytosis (Fig. 3B). Sequential exocytosis occurred anytime 
(Fig. 3C). 
Analysis of TEP imaging (Fig. 4A) showed that AdMunc18b-KR induced the 
most exocytotic events within 10 minutes (26.39 ± 2.89, 58 cells/6 islets), followed by 
AdMunc18b-WT (14.06 ± 1.39, 44 cells/7 islets), AdGFP (7.71 ± 0.89, 68 cells/8 islets), 
and AdMunc18b-E59K (5.40 ± 0.53, 75 cells/5 islets). I then examined how many of 
these exocytotic events involved sequential exocytosis (Fig. 4B). The rate of sequential 
exocytosis induced by the expression of AdMunc18b-KR (11.2% ± 1.4%) and 
AdMunc18b-WT (7.1% ± 1.7%) was ~3.2 and 2.0 times higher, respectively, than that 
induced by AdGFP expression (3.5% ± 1.0%; P < 0.05). Sequential exocytosis 
constituted only 1.6% ± 0.6% of the total exocytotic events in 
AdMunc18b-E59K-expressing β-cells. I assessed the percentage of cells undergoing 
sequential exocytosis (versus no sequential exocytosis). The percentage was higher in 
AdMunc18b-KR-transduced (74.1%) and AdMunc18b-WT-transduced (54.5%) cells 
than in AdGFP-transduced (30.9%) and AdMunc18b-E59K-transduced (13.3%) cells. 
These results indicate that the number of β-cells in which sequential exocytosis 
occurred increased upon expression of Munc18b-KR and Munc18-WT (Fig. 4C). 
In AdMunc18b-KR-infected β-cells, sequential SG-SG fusion accounted for 
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11.2% of the exocytotic events. Thus, primary exocytosis accounted for the majority, 
~89%, of the increase in total exocytotic events observed upon expression of 
AdMunc18b-KR (Fig. 4A). With AdMunc18b-WT expression, primary exocytosis 
accounted for 93% of the total exocytotic events. Therefore, it appears that a large 
increase in primary exocytosis and SG-SG fusion accounts for the overall increase in 
biphasic GSIS (Appendix Fig. 5A) resulting from Munc18b-KR and Munc18b-WT 
overexpression. Consistent with the results in Fig. 4A and B, Munc18b-E59K 
expression did not have a signiﬁcant dominant-negative effect on exocytosis by 
competing with endogenous Munc18b and thus did not cause a detectable reduction in 
GSIS (Appendix Fig. 5A, B) and sequential fusion events. 
Munc18b mediates long-chain sequential SG fusion 
Long-chain sequential exocytosis is the mode of exocytosis in highly efficient secretory 
cells such as mast cells (48), eosinophils (5), and pancreatic acinar cells, but not in less 
efficient cells such as β-cells. The molecular mechanism underlying long-chain 
sequential exocytosis is unknown. I postulated that upregulation of Munc18b expression 
or activity would increase the number of SGs participating in long-chain sequential 
SG-SG fusion. Therefore, I assessed the proportion of sequential SG fusion events with 
respect to chain length, as determined by the number of omega figures (Fig. 5). Higher 
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order long-chain sequential SG-SG fusion of up to five SGs was detected in 
AdMunc18b-KR-transduced and AdMunc18b-WT-transduced cells. In AdGFP- and 
AdMunc18b-E59K-expressing cells, sequential SG-SG fusion involved no more than 
two SGs.  
I occasionally detected very-long-chain sequential SG fusion in 
AdMunc18b-KR-expressing β-cells, with sequential fusion of seven insulin SGs 
(positions indicated by dashed circles in Fig. 6A). The time course of this exocytotic 
event showed an initial delay in the fusion of the second SG (Fig. 6B, numbers 
correspond to those in Fig. 6A), followed by rapid successive fusions through the fifth 
SG. The diameters of the puncta increased with each successive fusion. Events 2, 3, and 
4 were associated with abrupt changes in the shapes of the compound SGs and with 
increases in fluorescence. The direction of exocytosis (Fig. 6A, indicated by arrows) of 
the individual SGs varied from event to event. The focal plane did not change during the 
acquisition of images (see Fig. 6C): low magnification images demonstrated that the 
landmarks did not change. The rapid successive fusion might be attributable to “primed” 
insulin SGs (third to fifth SGs), and the resulting sustained plateau of fluorescence 
intensity (Fig. 6B) might reflect a slower flattening of compound SGs. The positions of 
the compound SGs (point of highest fluorescent intensity) tended to shift at each 
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sequential SG-SG fusion (dashed circles, Fig. 6A). This suggests that the fusion pores of 
primary SGs were stably maintained even though the positions of the SGs were altered 
by subsequent sequential fusion events.  
I investigated whether the average diameter of the SGs undergoing sequential 
exocytosis was same as that of SGs undergoing primary exocytosis. In islet cells 
transduced with Munc18b-WT, primary and sequential SGs were almost same size. 
Similarly, primary SGs and secondary sequential SGs were almost same size in 
AdMunc18b-KR-trancduced cells, AdMunc18b--E59K-transduced cells, and control 
AdGFP-transduced cells. However tertiary and subsequent SGs were larger in a 
diameter than primary and secondary SGs. Nevertheless, such long-order exocytosis 
was detected only in Munc18b-WT- or Munc18b-KR-expressing cells. The diameter of 
the SGs was about 0.3 μm, when estimated from the distinct increase in the fluorescence 
profile of the omega figures, as shown in Fig. 7. This value is consistent with values 
determined from the analysis of insulin SG size with EM (49) and TEP imaging (7), 
supporting the interpretation that increases in fluorescence in the present two-photon 
assay genuinely reflected exocytosis of insulin SGs. Tertiary and subsequent SGs were 
combined for analysis because of their low frequency of detection. The mean diameter 
of these SGs in Munc18b-WT- or Munc18b-KR-transduced cells was 361 nm and 377 
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nm, respectively, larger than the diameter of primary and secondary SGs. The estimation 
(Fig. 8) showed that the volume of tertiary and subsequent SGs was about 1.7 times 
greater than that of primary and secondary SGs. This suggests that tertiary and later SG 
fusion events involve fusion of vesicles generated by the fusion of two or more SGs.  
With regard to the latency time between sequential exocytotic events (Fig. 9A), 
there was no difference in the latency between the first and second sequential exocytotic 
events in AdMunc18b-KR- and AdMunc18b-WT-expressing cells vs. control and 
AdMunc18b-E59K-expressing cells. In AdMunc18b-KR- and AdMunc18b-WT- 
expressing cells, the latency between the second and third sequential exocytotic evens 
(Fig. 9B) and between subsequent sequential exocytotic events (Fig. 9C) was 
approximately 40 s, similar to the latency between the first two sequential exocytotic 
events, suggesting that primary exocytosis and secondary exocytosis are induced by the 
same mechanisms: the assembly of SNARE proteins, which are not assembled before 
stimulation. 
 
Depletion of endogenous Munc18b by shRNA reduces primary exocytosis by 50% 
and abrogates sequential SG-SG fusion 
I used Munc18b-E59K as a negative control because the E59K mutation is thought to 
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disrupt the interaction with the SNARE complex (Appendix Fig. 7), but it did not 
sufficiently suppress insulin exocytosis (Fig. 4). 
Finally, I examined the effect of endogenous Munc18b depletion on primary 
and sequential exocytosis in β-cells. A decrease in exocytosis upon depletion of 
endogenous Munc18b with lenti-Munc18b-shRNA (50) would support a role for 
Munc18b in potentiating exocytosis. I used a construct in which shRNA-Munc18b was 
linked to the fluorescent protein eCFP. Forty-eight hours after shRNA transfection of 
islets, we compared exocytotic events in eCFP-expressing/Munc18b-depleted β-cells 
and control lenti-eCFP-expressing β-cells. The total number of exocytotic events (Fig. 
10A) in Munc18b-depleted (67 cells/8 islets) and control β-cells (48 cells/8 islets) over 
a 10-min period of stimulation was 6.10 ±0.50 and 9.47 ± 0.65, respectively, 
representing a reduction of ~40% (P < 0.001). With depletion of Munc18b, the number 
of exocytotic events/cell (Fig. 10B) decreased by 35% in the first 5 min (49.4 ± 7.9 vs. 
31.9 ± 4.2 for control and Munc18b shRNA, respectively; P < 0.05) and by 41% in the 
second 5 min (44.2 ± 8.8 vs. 26.0 ± 5.1; P < 0.05) (Fig. 10B, right panel). The extent 
and pattern of the sustained reduction in exocytosis presented a corresponding image of 
GSIS in AdMunc18b-WT- or AdMunc18b-KR-expressing islets (Fig. 3A). I determined 
the number of exocytotic that involved sequential exocytosis (Fig. 10C). Sequential 
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exocytotic events in control β-cells constituted only 3.57% ± 0.59% of the total number 
of exocytotic events, consistent with a previous report (7). In contrast, Munc18b 
depletion reduced the percentage to 0.64% ± 0.22%, an 83% reduction (P < 0.001), 
indicating that sequential exocytosis was almost totally abrogated. 
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DISCUSSION 
This study demonstrated a role for Munc18b in insulin SG exocytosis as an accelerator 
and a prerequisite for one-half of biphasic GSIS. Furthermore, the study showed that 
Munc18b influences several modes of insulin secretion, including the SG-SG fusion 
mode, in rat β-cells.  
Secretion is essential for the transportation of proteins, peptides, minerals, and 
membrane components. Accordingly, it occurs in all tissues. Insulin secretion is required 
to accelerate glucose uptake in muscles and adipose tissues, to repress gluconeogenesis 
and accelerate glucose uptake in the liver for glucose homeostasis, and to relay 
messages that maintain fundamental biological processes, such as cell growth, in many 
target cells. The classification of the dynamics of SG exocytosis into “primary 
exocytosis” and “sequential exocytosis” was determined by electrophysiology 
experiments in eosinophils, neutrophils, mast cells, and the parotid gland (51). In 
primary exocytosis, only one SG fuses to the PM. In secondary exocytosis (sequential 
exocytosis in a broad sense), two or more SGs in the cytosol fuse with the SG at the PM, 
and/or one following SG fuse with the membrane of a former collapsing SG, the later in 
narrow sense. In recent years, tools such as two-photon microscopy have demonstrated 
that sequential exocytosis occurs in insulin-secreting cells (8) and adrenal medullary 
- 33 - 
 
cells (45). TEP imaging has shown that sequential exocytosis occurs in pancreatic acini 
(6), the nasal gland (44), and the salivary gland (52), consistent with the results obtained 
with static imaging of pituitary prolactin-secreting cells (53). Multigranular exocytosis 
(compound exocytosis) is another form of sequential exocytosis, in which one vesicle 
undergoes primary exocytosis, followed by the fusion of the primary vesicle with 
cytosolic vesicles generated by the fusion of multiple SGs. This multigranular 
exocytosis is particularly suited for the large amount of secretion by mast cells and 
eosinophils (54,55). In addition, a study using two-photon microscopy showed that 
sequential exocytosis occurred in insulin-secreting cells. However, the frequency was 
low, only 2%–5%, and the main secretion modes were primary exocytosis and another 
was sequential exocytosis of two SGs (7). Furthermore, long-chain sequential 
exocytosis or multigranular exocytosis has not been reported in glucose stimulated 
situations.  
In the present study, I used high-glucose stimulation with GLP-1 and IBMX to 
increase the frequency of exocytosis in order to study the exocytotic process (40,41). 
Under glucose stimulation with accelerants, the frequency of sequential exocytosis was 
3.5% (AdGFP-transfected controls), similar to the effect of accelerant observed in 
previous studies (7,8). In GSIS experiments with accelerants, the amount of total 
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exocytosis and sequential exocytosis was 1.8 and 2 times higher, respectively, in 
AdMunc18b-WT expressing cells than in control cells, consistent with the results in 
mouse insulin-secreting Min6 cells transduced with Munc18b (58). In cells transfected 
with dominant-positive Munc18b-KR, total exocytosis and sequential exocytosis were 
3.4 times and 3.2 times higher, respectively, than in control cells. Total exocytosis and 
sequential exocytosis were 0.7 times and 0.5 times lower, respectively, in 
Munc18b-E59K cells than in control cells. Upon depletion of Munc18b with 
Munc18b-shRNA, total exocytosis and sequential exocytosis were 0.6 times and 0.2 
times lower than in control cells. The suppressive effects of Munc18b-E59K 
overexpression on total and sequential exocytosis were weaker than those of 
Munc18b-shRNA, possibly because endogenous Munc18b was sufficient for 
maintaining exocytosis.  
Munc18b-KR enhanced exocytosis, increased the number of SGs in sequential 
exocytosis, and increased the frequency of cells exhibiting sequential exocytosis to a 
greater extent than did Munc18b-WT. These results provide insight into the function of 
Munc18b and suggest that the KR mutant promoted the reaction to insulin secretion. 
Munc18b might help the SNARE complex assemble tightly (Appendix Fig. 7; (22,59)). 
However, sequential exocytosis increased only 11% in Munc18b-KR-expressing cells. 
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The frequency of sequential exocytosis was higher than that of accidental exocytosis at 
overlap areas because insulin reduces serum glucose levels, even if inappropriate insulin 
discharge leads to hyperinsulinemia, which induces hypoglycemia and coma. These 
phenomena suggest a mechanism for the suppression of insulin secretion. Suppression 
might be influenced by binary binding between Munc18b and Syn-1 or by the relative 
amounts of Munc18b and the cognate SNARE complex. Other factors, such as Rabs, 
actin filaments, and phosphorylation, might positively and negatively affect insulin 
exocytosis.  
The present study showed that sequential exocytosis, including unusual chains 
of three or more SGs, occurred in Munc18b-transduced cells. A maximum of 8 
sequential SGs was detected in Munc18b-KR-transduced cells. The number of β-cells 
exhibiting sequential exocytosis was greatest after Munc18b-KR expression. The 
volume of sequential SGs was about twice that of primary SGs. The former might have 
been compound SGs or immature SGs (60). Compound SG exocytosis is not usually 
detected in GSIS, even with accelerants, but has been detected in cholinergic 
stimulation (61).  
SM protein/Syn complex has been known to inhibit binding to cognate SNARE 
partners (62). Binding of SM proteins to the SNARE complex is thought to induce a 
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state favorable for the tight assembly of the SNARE complex, leading to exocytosis 
(10). The relationship between SM proteins and cognate SNARE proteins was shown in 
IP studies and in vitro liposome fusion assays (19). Munc18a interacted mostly with 
Syn-1. Munc18b, which is 63% identical to Munc18a at the amino acid level, interacted 
mostly with Syn-2 and Syn-3. Munc18c, which is 45% identical to Munc18b at the 
amino acid level, interacted with Syn-4. The relationship of Munc18 proteins to 
SNAP25 and VAMPs depends on the identity of the syntaxin (63). 
How do Munc18b and SNARE proteins participate in primary and sequential 
exocytosis in insulin-secreting cells? We showed that Munc18a, b, and c and SNARE 
proteins were expressed in β cells and INS-1 cells (Figs. 1–3). Syn-1 -2, and -3 and 
SNAP25 mostly localized on the PM. Syn-2, -3, and -4 and SNAP23, SNAP25, and 
VAMP2 localized on the membrane of SGs. Moreover, the majority of Munc18a 
localized on the PM, while Munc18b localized on the PM and on SGs. In 
insulin-secreting cells, like in neuronal cells, Syx-1/SNAP25/VAMP2 appear to play a 
role in exocytosis, specifically primary exocytosis (64,7,65). SNAP25 plays a role in 
sequential exocytosis. This implies that SNAP25 diffuses on lipid membranes from the 
primary SG to subsequent fusing SGs during sequential exocytosis. (7,13). In other cells, 
such as mast cells and acinar cells, Syn-2 and Syn-3 are abundant and are known to 
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function in sequential exocytosis. Moreover, a recent study found that VAMP8 and 
Syn-3 mediated the primary exocytosis of newcomer insulin SGs and that Syn-3 
mediated insulin SG-SG fusion (25,66). 
Munc18b-KR, which showed weaker bind to Syn-1, augmented primary 
exocytosis. Munc18b bound to Syn-1 (competitively with Munc18a) and to Syn-2 at the 
PM to induce SNARE complex assembly. Preferential binding of Munc18b to Syn-2 
and Syn-3 rather than Syn-1 has been reported (22), which could account for the 
increase in sequential exocytosis mediated by Munc18b in this study. Consistently, a 
relationship between Syn-3 and primary/sequential exocytosis has been demonstrated 
(66). After stimulation of cells with glucose plus an accelerator, the amount of 
SNAP25/VAMP2 that coimmunoprecipitated with Syn-2 and Syn-3 increased. 
Munc18b and, to a greater extent, Munc18b-KR induced a tight assembly of proteins in 
the SNARE complex. A schema of the main SM and SNARE proteins localized in the 
insulin exocytotic machinery is shown in Fig. 11.  
I showed that Munc18b-mediated pathways in β-cells accounted for half of the 
biphasic GSIS and that Munc18b mediated the glucose-induced assembly of SNAREs 
for primary exocytosis and secondary exocytosis.  
Enhancing the activity or expression of Munc18b to activate SNARE 
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complexes and mobilize more insulin SGs (newcomer SGs) to the PM for sequential 
SG-SG fusion and primary exocytosis might compensate for the exocytotic defects of 
diabetic β-cells. Such an approach could be used in the treatment of diabetes to attain 
normoglycemic control (67). 
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FIGURE LEGENDS 
FIG. 1. TEP imaging of primary exocytosis in rat β-cells. 
(A) TEP imaging of rat islets in a solution containing 0.3 mM Alexa 594 hydrazide. 
The ﬂuorescence distinguishes several adjacent β-cells in the islet, along with the 
intercellular space and blood vessels. Scale bar, 10 μm. On a representative cell, the 
white circle (right panel (a)–(c)) indicates the location of three exocytotic events (B). 
Scale bars, left panel: 10 μm; right panel: 5 μm. 
(B) Three examples of TEP imaging of single insulin SG exocytosis (single granule) 
in an AdGFP-transduced rat islet stimulated with 20 mmol/L glucose plus 10 nmol/L 
GLP-1 and 150 μmol/L IBMX. The imaging interval was 1.2 sec. An omega 
construction appeared when the SG(s) coalesced with the PM. The numbers below 
each panel indicate the time after the onset of exocytosis. Dashed white circles show 
the position of the omega construction in a former panel. Arrows point in the direction 
of SG fusion toward the cell interior. (a) and (b) show exocytotic events on the edge 
of a β-cell, and (c) shows an exocytotic event at the β-cell surface. Scale bar, 1 μm. 
(C) Time course of ﬂuorescence in the area containing the exocytotic events. Vertical 
bars indicate the times when the images in B were acquired. The ﬂuorescence value 
before exocytosis was set to zero. A.U., arbitrary units. 
(D) The cartoon illustrates primary exocytosis (single SG fusion) in a cross-sectional 
image. Initially, intracellular, unfused insulin granules are not detected because the 
Alexa 594 probe is hydrophilic. Once the SG fused to the PM, the fusion pore opened 
permitting the probe influx into the interior of the SG. The membranes of the SG and 
PM merge during membrane concrescence. The fluorescence intensity decreases as 
the volume of internal space in the SG decreases and then returns to zero as the 
membrane flattens at the end of exocytosis. Most insulin granule exocytosis involves 
full fusion (68). 
 
FIG. 2. Munc18b mediates primary exocytosis and sequential SG-SG fusion in rat 
β-cells. 
(A) The Alexa 594 fluorescence distinguishes several adjacent β-cells in the islet, 
along with small blood vessels (white arrowheads) and major blood vessels (white 
arrows). The white square shows the location of the exocytotic images shown in B. 
Scale bar, 10 μm. 
(B) Example of sequential exocytosis (two granules) involving two SGs in an 
AdMunc18b-KR-transduced rat islet stimulated as described in Fig. 1. The imaging 
interval was 0.6 sec. The numbers below each panel indicate the time after the onset 
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of exocytosis. Dashed circles show the position of the omega construction in a former 
panel. Arrows point in the direction of SG fusion towards the cell interior. Scale bar, 1 
μm.  
(C) Time course of fluorescence in the area containing the exocytotic events. Vertical 
bars indicate the times when the images in B were acquired. The fluorescence value 
before exocytosis was set to zero. Panels A–C were reproduced from Diabetes, vol. 62 
p. 2416–2428 (2013). 
(D) A schematic illustration of primary and sequential exocytosis. An insulin granule 
from exocytosis to full membrane fusion is shown. The first single granule fuses with 
the PM as in primary exocytosis (Fig. 1D), and subsequent SGs with distinct 
directionality sequentially fuse to the previous collapsing SG. 
 
FIG. 3. Munc18b-WT or Munc18b-KR changes total and sequential exocytosis in 
rat β-cells. 
The graphs display exocytosis data captured every 1 min during 10 min of stimulation 
with high glucose in the presence of an accelerator. 
(A) Total number of exocytotic events was calculated as the average number of 
exocytotic eventscell-1min-1 in β-cells from islets expressing AdGFP (8 islets, 68 
cells), AdMunc18b-WT (7 islets, 44 cells), AdMunc18b-KR (6 islets, 58 cells), and 
AdMunc18b-E59K (5 islets, 75 cells), as described above (Figs. 1, 2).  
(B) The fraction of total exocytotic events occurring through primary exocytosis. 
(C) The fraction of total exocytotic events occurring through sequential exocytosis.  
 
FIG. 4. Munc18b or Munc18b-KR accelerates GSIS in rat β-cells. 
(A) Total number of exocytotic events was calculated as the number of exocytotic 
eventscell-1min-1 in β-cells from islets expressing AdGFP, AdMunc18b-WT, 
AdMunc18b-KR, and AdMunc18b-E59K during a 10-min period of stimulation, as in 
Fig. 3A. 
(B) The fraction of total exocytotic events occurring through sequential exocytosis. 
The number of secondary exocytotic events considered to be sequential exocytosis 
was expressed as the percentage of the total number of exocytotic events determined 
in (A).  
(C) Proportion of cells showing sequential exocytosis among all cells undergoing 
primary and/or sequential exocytosis. 
The results in (A), (B), and (C) represent the mean ± SEM. The data was analyzed 
using the Steel-Dwass test for multiple comparisons with AdGFP as the control, *P < 
0.05, **P < 0.01, ***P < 0.001. 
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FIG. 5. Munc18b induces long-chain sequential SG fusion involving three or more 
SGs. 
The ordinate represents the ratio for increasing chain length of sequential SG fusion 
(the abscissa) events relative to total number of sequential exocytotic events in β-cells 
transfected with AdGFP (8 islets, 68 cells), AdMunc18b-WT (7 islets, 44 cells), 
AdMunc18b-KR (6 islets, 58 cells), or AdMunc18b-E59K (6 islets, 88 cells). 
 
FIG. 6. Munc18b mediates long-chain sequential SG fusion. 
(A) TEP imaging of long-chain sequential exocytosis of insulin SGs in a rat β-cell 
treated expressing AdMunc18b-KR and stimulated with 20 mmol/L glucose plus 10 
nmol/L GLP-1 and 150 μmol/L IBMX. Dashed circles show the positions of an omega 
construction in a former panel. Arrows indicate the direction of an oncoming SG 
undergoing sequential fusion. 
(B) Time course of the fluorescence intensity within the region containing all the 
exocytotic events shown in (A). *Independent single exocytotic event, occasionally 
seen close to compound SGs (data not shown). Scale bars, 1 µm. A.U., arbitrary units. 
(C) The low magnification images correspond to those shown in Fig. 4B and Fig. 6A. 
The large oblique areas (red space surrounded by a white dotted line) showed high 
fluorescence intensity that did not change. These represent intercellular spaces, which 
served as landmarks to indicate that the focal plane did not deviate during the 
acquisition of successive images. An example of exocytosis is shown in the upper 
middle area of each panel, demonstrating the changes in fluorescence intensity and 
pattern that reflect sequential SG-SG fusion, indicated by the numbered arrows. Note 
the other scattered, independent exocytosing vesicles that appear in the right lower 
regions between the two oblique fluorescent areas in the later panels. 
The figure was reproduced from Diabetes, vol. 62 p. 2416–2428 (2013) and 
supplementary data. 
 
FIG. 7. Frequency distribution of SG diameters estimated by ΔV-TEPIQ 
(image-based quantification) analysis of TEP imaging. 
Using the ΔV-TEPIQ method, the fluorescence intensity of the vesicle (FV) was 
divided by FE, which represents the fluorescence intensity per unit area in an 
xy-image of a solution with an infinite depth, as ΔV = FV/FE/Pxy(0), where Pxy(0) is 
the efficiency of focal illumination (0.56 in our setup). Using this analysis, I found no 
significant difference in the diameters of single, first, and second SGs in each 
adenovirus-infected group (the significance of the differences was evaluated using 
Scheffé’s method for multiple comparisons; data not shown). The black dotted lines 
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represent the Gaussian distribution of the means and the standard deviation of single 
granule fusion. The analysis was performed using β-cells transfected with AdGFP (56, 
10, and 10 omega constructions for single, first, and second granules, respectively), 
AdMunc18b-WT (76, 22, 25, and 17 for single, first, second, and third and later 
granules, respectively), AdMunc18b-KR (37, 29, 29, and 25 for single, first, second, 
and third and later granules, respectively), and AdMunc18b-E59K (38, 8, and 8 for 
single, first, and second granules, respectively). “Single” means only a single SG 
fusion in primary exocytosis and excludes the first SG fusion in sequential exocytosis. 
“First,” “second,” and “third or later” mean the first SG, the second SG, and third and 
the subsequent SGs that exocytosed via sequential exocytosis, respectively.  
The figure was reproduced from Diabetes, vol. 62 p. 2416–2428 (2013) and 
supplementary data. 
 
FIG. 8. Estimated volume of fused SGs.  
As described in Figure 7, using the ΔV-TEPIQ method, volumes were estimated for 
the single SG in primary exocytosis and for first, second, and third or later SGs in 
sequential exocytosis. The volumes of primary and second exocytotic SGs were not 
significantly different. On the other hand, the volume of third or later exocytotic SGs 
was larger than the volume of the other types of SGs. The results shown represent the 
mean ± SEM. The data was analyzed by Scheffé’s test for multiple comparisons ***P 
< 0.001. 
 
FIG. 9. Latency between SG-SG fusion.  
I defined the lag-time for SG fusion with the preceding fused SG. 
(A) The time from the first exocytotic event to the second exocytotic event was 
determined for islets transfected with AdGFP, AdMunc18b-WT, AdMunc18b-KR, or 
AdMunc18b-E59K, as in Fig. 3. There was no significant difference between cells 
transfected with AdGFP (counted exocytosis n = 24), AdMunc18b-WT (n = 51), 
AdMunc18b-KR (n = 188), and AdMunc18b-E59K (n = 17) when the data was 
assessed with Scheffé’s test for multiple comparisons.  
(B) The time from the second to the third exocytotic event is shown. There was no 
significant difference between cells transfected with AdMunc18b-WT (n = 16) and 
AdMunc18b-KR (n = 58) when the data was assessed with the Mann-Whitney U test. 
(C) The time from the third (or later) exocytotic event to the subsequent exocytotic 
event. There was no significant difference between cells transfected with 
AdMunc18b-WT (n = 8) and AdMunc18b-KR (n = 50) when the data was assessed 
with the Mann-Whitney U test. Data for AdGFP and AdMunc18b-E59K are not 
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displayed because exocytosis involving more than two SGs was not detected in islets 
expressing these proteins.  
 
FIG. 10. Munc18b depletion reduces primary and sequential exocytosis in rat 
β-cells. 
TEP images of single SG exocytosis and SG-SG fusion in islets treated with 
lenti-shRNA/Munc18b-eCFP (67 cells, 8 islets) or lenti-eCFP (control; 48 cells, 8 
islets) and stimulated for 10 min with 20 mmol/L glucose plus 10 nmol/L GLP-1 and 
150 μmol/L IBMX. The number of exocytotic events was calculated.  
(A) Total number of exocytotic events. (B) Number of exocytotic events within each 
indicated time interval during the 10-min recording. Right panel: summation of the 
first 5 min and second 5 min of recording. (C) Secondary exocytotic events 
considered to be sequential exocytosis were expressed as the percentage of the total 
number of exocytotic events determined in (A). The results represent the mean ± SEM, 
*P < 0.05, ***P < 0.001. Data in A, and the right panels of B and C were analyzed by 
t-test; data in the left panel of B was analyzed with Tukey’s test (vs. control) for 
multiple comparisons.  
The figure was reproduced from Diabetes, vol. 62 p. 2416–2428 (2013). 
 
FIG. 11. Schema for the arrangement of exocytotic molecules and the exocytotic 
process in insulin-secreting cells.  
In the insulin secretory pathway, stimulation with glucose and/or an incretin such as 
GLP-1 or gastric inhibitory peptide promotes SG motion or induces deeper SGs to 
move near the PM for exocytosis by increasing cAMP and the cytosolic concentration 
of free Ca
2+
. The main molecules involved in insulin secretion are SNARE proteins 
and SM proteins. Those proteins localize on the lipid bilayer of the PM and SGs. 
 For primary and secondary exocytosis, working SM and SNARE proteins are 
shown in the lower panel. In primary exocytosis, Munc18b promotes the formation of 
the Syn-1, SNAP25, and VAMP2 complex, similar to Munc18a. In sequential 
exocytosis, Munc18b might activate SNARE complex formation by orchestrating 
Syn-2 or -3, VAMPs, and the transfer of SNAP25 from the cell membrane to the 
bilayer of primary fused SGs. Moreover, long-chain sequential exocytosis might 
involve complexes containing other SNAPs, such as SNAP23, other VAMPs, such as 
VAMP8, and Syn-2 or -3, whose formation is accelerated by Munc18b. 
- 66 - 
 
APPENDICES MATERIALS AND METHODS 
The experiments mentioned below were performed by my collaborators, Professor 
Gaisano, Dr. Lam and his colleagues, Dr. Dolai, Dr. He, Dr. Qin, Dr. Liang, Dr. Zhu, Dr. 
Kang, Dr. Liu Dr. Xie, Dr. Wan, Dr. Bin, Professor Shuzo Sugita (University of Toronto, 
Toronto, Ontario, Canada). 
Cell culture and rat islet perifusion assays 
Islets from Sprague Dawley rats (275–300 g) were isolated by collagenase digestion as 
described previously (1). Islets and INS-1 cells (823/13; C. Newgard, Duke University, 
Durham, NC, USA) were cultured in RPMI 1640 medium. Batches of 30 rat islets (or 
INS-1 cells) were transduced with Munc18b lenti-shRNA (siRNA for INS-1) or 
AdMunc18b constructs, loaded in perifusion chambers (~1.3-mL capacity), and perfused 
at a flow rate of ~1 mL/min (37°C). Cells were stimulated with glucose in the presence 
or absence of 10 nM GLP-1 (Sigma-Aldrich, St. Louis, MO, USA) and 150 µM IBMX 
(Sigma-Aldrich), as indicated. Insulin secretion was measured with RIAs (Linco 
Research, St. Louis, MO, USA). The experiments were approved by the Animal Care 
Committees of the University of Toronto. 
Silencing Munc18b expression and adenovirus construction 
Endogenous Munc18b was silenced using two strategies, siRNA in INS-1 cells and 
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lenti-shRNA in islets. For siRNA experiments, two 64-base pair siRNA duplex 
sequences targeting Munc18b were created with reference to rat Munc18b cDNA 
(GenBank Accession Number AF263346). Sense, antisense, and control scrambled 
sequences were used. INS-1 cells were transfected using Lipofectamine2000 
(Invitrogen, Burlington, ONT, Canada). 
Munc18b-WT and Munc18b mutants tagged with GFP in a separate 
transcription cassette (2) were subcloned into a pAdTrack shuttle vector and inserted 
into a pAdeasy-1 backbone. Positive clones were used to transfect HEK293 cells. 
Viruses released from single plaques were then amplified to high titers. 
Confocal immunoﬂuorescence microscopy 
As previously described (3), dispersed islet β-cells were plated on glass 
coverslips, fixed with 2% paraformaldehyde, and rinsed in PBS for 5 min. The 
preparations were then blocked with 5% normal goat serum/0.1% saponin for 0.5 h at 
25°C. The cells were then washed, incubated with the indicated primary antibodies for 1 
h at a 1:100 dilution, and stained with the appropriate fluorochrome (fluorescein 
isothiocyanate)-conjugated secondary antiserum (1 h, 25°C). The coverslips were then 
mounted on slides in a fading retarder, 0.1% p-phenylenediamine in glycerol, and 
examined using a Leica DMIRE2 inverted confocal microscope system (Leica 
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Microsystems GmbH, Wetzlar, Germany) equipped with a Hamamatsu Back-Thinned 
EM-CCD camera (Hamamatsu Photonics, Shizuoka, Japan) and spinning disk confocal 
scan head. The unit was equipped with four separate diode-pumped solid state laser 
lines (Spectral Applied Research Inc., Concord, Ontario, Canada) at 405 nm, 491 nm, 
561nm, 638 nm; an ASI motorized XY stage; and an Improvision Piezo Focus Drive 
(for Z-scans, 0.1-μm steps) (PerkinElmer, Waltham, MA). The equipment was driven by 
Volocity Acquisition software (PerkinElmer) and powered by an Apple Power Mac G5 
computer. Cells were visualized with a 63× objective lens, and lasers at 491 nm, 561 nm, 
and 638 nm were used to excite FITC, Texas Red, and Cy5 fluorophores, respectively. A 
deconvolution algorithm was applied to the images to remove out-of-focus background 
noise.  
Immunoprecipitation 
Immunoprecipitation (IP) was performed as previously described (3). INS-1 cells 
(70%–75% confluent) were transduced with 1) Munc18b siRNA or scrambled nonsense 
siRNA or 2) wild-type or mutant AdMunc18b or control AdGFP. INS-1 cell lysates were 
immunoprecipitated with antibodies (1.2–2.0 µg) specific to Syn-1A, -2, or -3. 
Coprecipitated proteins were identified with western blotting using the indicated 
antibodies. All antibodies used were commercial antibodies except Munc18c (Y. Tamori, 
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Kobe University, Kobe, Japan), VAMP8 (W. Hong, Institute of Molecular and Cell 
Biology, Singapore), Syn-4 (J.E. Pessin, Albert Einstein College of Medicine, Bronx, 
NY, USA), and Munc18b (P.P.L. Lam, University of Toronto, Toronto, Canada) (2). 
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APPENDICES FIGURE LEGENDS 
Appendix FIG. 1. Munc18b and SNARE expression in rat islets. 
Pancreatic β-cells (rat islets, INS-1 cells) expressed SM proteins and syntaxins. Rat 
pancreatic acini and brain tissues were used as controls for sequential (compound) 
exocytosis model in the absence of Munc18a and for basal exocytosis mediated by 
classical SNARE proteins, respectively. The figure was reproduced from Fig. 1A in 
Diabetes, 62 p. 2418 (2013) (4). 
 
Appendix FIG. 2. Munc18b localizes to insulin granules and the plasma membrane 
in rat β-cells. 
In immunofluorescence analysis, cognate Munc18b, Syn-2, and Syn-3 were abundant 
in insulin SGs in rat β-cells. Cognate Munc18a and Syn-1A were abundant in the PM. 
The images are representative of four independent experiments. Scale bars, 10 μm. 
The figure was reproduced from Fig. 1B in Diabetes, 62 p. 2418 (2013) (4). 
 
Appendix FIG. 3. Depletion of Munc18b in islets reduces biphasic GSIS.  
(A) Munc18b depletion in rat islets by lenti-Munc18b shRNA/eCFP vs. lenti-eCFP 
control. Top panel:Representative blots. Bottom panel: Analysis of three experiments, 
shown as means ± SEM. *P < 0.05, **P < 0.01. 
(B) Islet perifusion assays of 48 h lenti-shRNAMunc18b-eCFP (vs. lenti-eCFP 
[control]) depletion of endogenous Munc18b in rat islets showing reduction of GSIS 
and GLP-1 (10 nM) plus IBMX (150 μM)-potentiated GSIS, shown as means ± SEM 
of three independent experiments, and AUC analysis; *P < 0.05, ***P < 0.001.  
G, glucose. These figures were reproduced from Fig. 1C, D in Diabetes, 62 p. 2418 
(2013) (4). 
 
Appendix FIG. 4. Overexpression of Munc18b or Munc18b mutants in islets does 
not affect SM or SNARE proteins.  
(A) Expression of AdMunc18b proteins (-WT, -KR, -E59K) in rat islets did not affect 
the expression of SNARE proteins or other SM proteins. The results are representative 
of three independent experiments. The analysis of Munc18b protein expression is 
shown in the bottom panel. The level of Munc18b protein in cells overexpressing the 
WT or mutant proteins was higher than in control cells. *P < 0.05 by ANOVA. 
(B) Confocal imaging showed that AdMunc18b mutants did not affect the targeting of 
Syn-2 or Syn-3 to insulin SGs in rat β-cells. The results are representative of four 
independent experiments. Scale bars, 10 μm. The figure was reproduced from Fig. 2A, 
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B Diabetes, 62 p. 2419 (2013) (4). 
 
Appendix FIG. 5. Munc18b is a mediator of GSIS in pancreatic islet β-cells.  
(A) Islet perifusion assays showed that expression of AdMunc18b mutants in rat islets 
affected GSIS. The results shown are the mean ± SEM from three or four sets of 
experiments, in which the four conditions were analyzed simultaneously in each 
experiment. Bottom panels show the quantification of the AUC analysis of first-phase 
(11–22 min) and second-phase (22–40 min) GSIS. *P < 0.05, **P < 0.01, ***P < 
0.001 by one-way ANOVA. A symbol of asterisk without a black comparison bar 
showed a comparison with AdGFP (contral). 
(B) Islet perifusion assays showed that expression of AdMunc18b mutants in rat islets 
affected GSIS potentiated by 10 nM GLP-1 plus 150 µM IBMX. The results shown 
are the mean ± SEM from three or four sets of experiments, in which the four 
conditions were analyzed simultaneously in each experiment. Bottom panels show the 
quantification of the AUC analysis of first-phase (11–22 min) and second-phase 
(22–40 min) GSIS. *P < 0.05, **P < 0.01, ***P < 0.001 by one-way ANOVA. A 
symbol of asterisk without a black comparison bar showed a comparison with AdGFP 
(contral). 
(C) Effects of AdMunc18b mutants on GSIS and 10 nM GLP-1 plus 150 µM 
IBMX-potentiated GSIS in INS-1 cells. The results shown are the mean ± SEM from 
three independent experiments performed in duplicate or triplicate (n = 6–8). *P < 
0.05 by ANOVA and Scheffé’s test. A symbol of asterisk without a black comparison 
bar showed a comparison with AdGFP (contral). 
The figure was reproduced from Fig. 2C-E Diabetes, 62 p. 2419 (2013) (4). 
 
Appendix FIG. 6. Munc18b depletion in INS-1 cells disrupts SM-activated SNARE 
complex formation. 
INS-1 cells transduced with Munc18b siRNA or control scrambled RNA were 
maintained under basal conditions (0.8 mM glucose) or stimulated with 16.7 mM 
glucose plus 10 nM GLP-1 with IBMX (150 µM). Cell lysates were 
coimmunoprecipitated (left panels) with antibodies against Syn-1A (A), Syn-2 (B), or 
Syn-3 (C). The corresponding right panels, showing the “Input” controls (25 µg 
protein, total INS-1 lysates), confirmed that Munc18b levels were reduced and that 
levels of the indicated SNARE proteins were unchanged. The results shown are 
representative of three independent experiments. Data from densitometry analyses are 
not shown. 
The figure was reproduced from Fig. 3 in Diabetes, 62 p. 2421 (2013) (4). 
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Appendix FIG. 7. A Munc18b gain-of-function mutant increases SM-activated 
SNARE complex formation. 
INS-1 cells were transduced with AdMunc18 mutants, maintained under 
non-stimulated (lanes 1–4) or stimulated (lanes 5–8) conditions as in Fig. 3, and used 
for coimmunoprecipitation experiments (left panels) with antibodies against Syn-1A 
(A), Syn-2 (B), or Syn-3 (C). The expression of exogenous Munc18b (tagged with 
Myc) was detected with a Myc antibody. The corresponding right panels, showing 
input controls (25 µg protein, total INS-1 lysates), indicated that SNARE protein 
levels were unchanged. The results shown are representative of three independent 
experiments. Data from densitometry analyses are not shown.  
The figure was reproduced from Fig. 4 in Diabetes, 62 p. 2422 (2013) (4). 
 
 
